55.2: 5-(3-chloro-2-methoxyphenyl)-3-ethyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione (compound 55)
Similarly to example 51.4, starting from 300 mg (0.9 mmol) of [5-(3-chloro-2-methoxyphenyl)-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid and 239 mg (1 mmol) of 3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one (prepared as described in example 16.4), 395 mg (78%) of 5-(3-chloro-2-methoxyphenyl)-3-ethyl-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione is obtained in the form of a white solid with a melting point of 219Â° C.